Lessons on non-progression of HIV disease from monkeys

Frontiers in Immunology

Volumn 4, Issue MAR, 2013, Pages

  Nehete, Pramod N ^a   Singh, Shailbala ^b   Jagannatha Sastry, K ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CD4+ T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE COURSE; GENETIC LINKAGE; HAPLORHINI; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGENETICS; INFECTION CONTROL; NONHUMAN; RHESUS MONKEY; SEQUENCE HOMOLOGY; SIMIAN IMMUNODEFICIENCY VIRUS; SURVIVAL TIME; VIRUS LOAD;

EID: 84883804757     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00064     Document Type: Article

References (32)

1. Barry, A. P., Silvestri, G., Safrit, J. T., Sumpter, B., Kozyr, N., McClure, H. M., et al. (2007). Depletion of CD8+ cells in sooty mangabey monkeys naturally infected with simian immunodeficiency virus reveals limited role for immune control of virus replication in a natural host species. J. Immunol. 178, 8002-8012.
2. Betts, M. R., Nason, M. C., West, S. M., De Rosa, S. C., Migueles, S. A., Abraham, J., et al. (2006). HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107, 4781-4789.
3. Buchbinder, S. P., Mehrotra, D. V., Duerr, A., Fitzgerald, D. W., Mogg, R., Li, D., et al. (2008). Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372, 1881.
4. Cecchinato, V., and Franchini, G. (2010). Th17 cells in pathogenic SIV infection of macaques. Curr. Opin. HIV AIDS 5, 141.
5. Dandekar, S., George, M. D., and Bäumler, A. J. (2010). Th17 cells, HIV and the gut mucosal barrier. Curr. Opin. HIV AIDS 5, 173.
6. Deeks, S. G., and Walker, B. D. (2007). Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 27, 406-416.
7. Favre, D., Lederer, S., Kanwar, B., Ma, Z.-M., Proll, S., Kasakow, Z., et al. (2009). Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog. 5:e1000295. doi: 10.1371/journal.ppat.1000295
8. Fellay, J., Ge, D., Shianna, K. V., Colombo, S., Ledergerber, B., Cirulli, E. T., et al. (2009). Common genetic variation and the control of HIV-1 in humans. PLoS Genet. 5:e1000791. doi: 10.1371/journal.pgen.1000791
9. Freel, S. A., Lamoreaux, L., Chattopadhyay, P. K., Saunders, K., Zarkowsky, D., Overman, R. G., et al. (2010). Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination. J. Virol. 84, 4998-5006.
10. Goulder, P. J., and Watkins, D. I. (2004). HIV and SIV CTL escape: implications for vaccine design. Nat. Rev. Immunol. 4, 630-640.
11. Goulder, P. J. R., and Watkins, D. I. (2008). Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat. Rev. Immunol. 8, 619-630.
12. Hansen, S. G., Ford, J. C., Lewis, M. S., Ventura, A. B., Hughes, C. M., Coyne-Johnson, L., et al. (2011). Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473, 523-527.
13. He, H., Nehete, P. N., Nehete, B., Wieder, E., Yang, G., Buchl, S., et al. (2011). Functional impairment of central memory CD4 T cells is a potential early prognostic marker for changing viral load in SHIV-infected rhesus macaques. PLoS ONE 6:e19607. doi: 10.1371/journal.pone.0019607
14. Jacquelin, B., Mayau, V., Targat, B., Liovat, A.-S., Kunkel, D., Petitjean, G., et al. (2009). Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J. Clin. Invest. 119, 3544.
15. Kalams, S. A., and Walker, B. D. (1998). The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J. Exp. Med. 188, 2199-2204.
16. Kanwar, B., Favre, D., and McCune, J. M. (2010). Th17 and regulatory T cells: implications for AIDS pathogenesis. Curr. Opin. HIV AIDS 5, 151.
17. Kestier, H. W., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D., et al. (1991). Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662.
18. Kornfeld, C., Ploquin, M., Pandrea, I., Faye, A., Onanga, R., Apetrei, C., et al. (2005). Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J. Clin. Invest. 115, 1082-1091.
19. Loffredo, J. T., Bean, A. T., Beal, D. R., León, E. J., May, G. E., Piaskowski, S. M., et al. (2008). Patterns of CD8+ immunodominance may influence the ability of Mamu-B* 08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication. J. Virol. 82, 1723-1738.
20. Mercier, G. T., Nehete, P. N., Passeri, M. F., Nehete, B. N., Weaver, E. A., Templeton, N. S., et al. (2007). Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules. Vaccine 25, 8687-8701.
21. Migueles, S. A., Sabbaghian, M. S., Shupert, W. L., Bettinotti, M. P., Marincola, F. M., Martino, L., et al. (2000). HLA B* 5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc. Natl. Acad. Sci. U.S.A. 97, 2709-2714.
22. Milush, J. M., Mir, K. D., Sundaravaradan, V., Gordon, S. N., Engram, J., Cano, C. A., et al. (2011). Lack of clinical AIDS in SIV-infected sooty mangabeys with significant CD4+ T cell loss is associated with double-negative T cells. J. Clin. Invest. 121, 1102.
23. Mudd, P. A., Martins, M. A., Ericsen, A. J., Tully, D. C., Power, K. A., Bean, A. T., et al. (2012). Vaccine-induced CD8+ T cells control AIDS virus replication. Nature 491, 129-133.
24. Nehete, P. N., Chitta, S., Hossain, M. M., Hill, L., Bernacky, B. J., Baze, W., et al. (2001). Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model. Vaccine 20, 813-825.
25. Nehete, P. N., Lewis, D. E., Tang, D. N., Pollack, M. S., and Sastry, K. J. (1998). Presence of HLA-C-restricted cytotoxic T-lymphocyte responses in long-term nonprogressors infected with human immunodeficiency virus. Viral Immunol. 11, 119-129.
26. Nehete, P. N., Nehete, B. P., Hill, L., Manuri, P. R., Baladandayuthapani, V., Feng, L., et al. (2008). Selective induction of cell-mediated immunity and protection of rhesus macaques from chronic SHIVKU2 infection by prophylactic vaccination with a conserved HIV-1 envelope peptide-cocktail. Virology 370, 130.
27. Nehete, P. N., Nehete, B. P., Manuri, P., Hill, L., Palmer, J. L., and Sastry, K. J. (2005). Protection by dendritic cells-based HIV synthetic peptide cocktail vaccine: preclinical studies in the SHIV-rhesus model. Vaccine 23, 2154-2159.
28. Premkumar, D. R., Ma, X.-Z., Maitra, R. K., Chakrabarti, B. K., Salkowitz, J., Yen-Lieberman, B., et al. (1996). The nef gene from a long-term HIV type 1 nonprogressor. AIDS Res. Hum. Retroviruses 12, 337-345.
29. Saksena, N. K., Rodes, B., Wang, B., and Soriano, V. (2007). Elite HIV controllers: myth or reality. AIDS Rev. 9, 195-207.
30. Sette, A., Sidney, J., Bui, H.-H., del Guercio, M.-F., Alexander, J., Loffredo, J., et al. (2005). Characterization of the peptide-binding specificity of Mamu-A* 11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity. Immunogenetics 57, 53-68.
31. Silvestri, G., Fedanov, A., Germon, S., Kozyr, N., Kaiser, W. J., Garber, D. A., et al. (2005). Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts. J. Virol. 79, 4043-4054.
32. Weaver, E. A., Nehete, P. N., Nehete, B. P., Buchl, S. J., Palmer, D., Montefiori, D. C., et al. (2009). Protection against mucosal SHIV challenge by peptide and helper-dependent adenovirus vaccines. Viruses 1, 920-938.